Aditya Birla Sun Life International Equity Fund vs ITI Pharma and Healthcare Fund
Direct Plan, Growth option · Data as on 29-10-2026
Aditya Birla Sun Life International Equity Fund is a Thematic fund and ITI Pharma and Healthcare Fund is a Thematic fund. In the 3 years to 30-10-2026, Aditya Birla Sun Life International Equity Fund (Direct) returned 24.5% a year and ITI Pharma and Healthcare Fund (Direct) returned 20.3% a year. Aditya Birla Sun Life International Equity Fund charges 2.00% a year and ITI Pharma and Healthcare Fund 0.89% (Direct plans). Their portfolios overlap 0.0%: they hold 0 of the same securities.
Aditya Birla Sun Life International Equity Fund
Thematic
- 3 year return
- 24.5%
- Expense ratio
- 2.00%
- NAV
- ₹56.75
ITI Pharma and Healthcare Fund
Thematic
- 3 year return
- 20.3%
- Expense ratio
- 0.89%
- NAV
- ₹19.46
Which is better, Aditya Birla Sun Life International Equity or ITI Pharma and Healthcare? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Aditya Birla Sun Life International Equity returned more over 3 years: 24.5% a year against 20.3%.
- Aditya Birla Sun Life International Equity returned more over 1 year: 14.0% against 9.4%.
- ITI Pharma and Healthcare costs less: 0.89% a year against 2.00% (Direct plans).
- Aditya Birla Sun Life International Equity swung less over 3 years: a standard deviation of 12.3% a year against 14.2%.
- Aditya Birla Sun Life International Equity fell less in its worst fall since 11-11-2021: −16.6% against −17.7%.
- Aditya Birla Sun Life International Equity holds 93.5% of the fund in foreign stocks; ITI Pharma and Healthcare 0.0%.
- ITI Pharma and Healthcare holds more in large companies: 35.9% of the fund in large caps against 0.0%.
- Aditya Birla Sun Life International Equity is the larger fund: ₹352 Cr against ₹266 Cr.
- Their portfolios overlap 0.0%: 0 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Aditya Birla Sun Life International Equity Fund | ITI Pharma and Healthcare Fund |
|---|---|---|
| Fund house | Aditya Birla Sun Life Mutual Fund | ITI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹352 Cr (30-09-2026) | ₹266 Cr (30-09-2026) |
| NAV | ₹56.75 (Direct) | ₹19.46 (Direct) |
| Expense ratio (Direct) | 2.00% | 0.89% |
| Expense ratio (Regular) | 2.55% | 2.59% |
| Riskometer | Very High | Very High |
| Benchmark | S&P Global 1200 TRI | NIFTY Healthcare TRI |
| Launch date | 31-10-2007 | 08-11-2021 |
| Minimum investment | ₹1,000 | ₹5,000 |
| Lock in | None | None |
| Fund managers | Dhaval Joshi | Animesh Singh, Nilay Dalal |
| Exit load | Exit load of 1%, if redeemed within 30 days. | Exit load of 0.50%, if redeemed within 3 months. |
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund (Direct) | −1.59% | +3.00% | +4.05% | +13.97% | +24.46% | +11.86% | +13.70% |
| ITI Pharma and Healthcare Fund (Direct) | 0.00% | −1.04% | +11.74% | +9.43% | +20.30% | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: Year-wise Returns
| Year | Aditya Birla Sun Life International EquityAditya Birla Sun Life International Equity | ITI Pharma and HealthcareITI Pharma and Healthcare |
|---|---|---|
| 2026to date | +12.49% | +14.07% |
| 2025 | +35.28% | −8.24% |
| 2024 | +8.06% | +43.95% |
| 2023 | +9.37% | +34.39% |
| 2022 | −1.36% | −6.68% |
| 2021 | +14.47% | -- |
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: Rolling Returns
Every holding period of both funds, against Nifty Healthcare Index TRI, the benchmark of ITI Pharma and Healthcare Fund
Rolling returns
Every 3-year holding period, 486 of them, one for each trading day from 11-11-2024 to 29-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Aditya Birla Sun Life International Equity Fund (Direct)
ITI Pharma and Healthcare Fund (Direct)
Nifty Healthcare Index TRI
to
Jan 2025May 2022
to
May 2025Sept 2022
to
Sept 2025Jan 2023
to
Jan 2026May 2023
to
May 2026Sept 2023
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life International Equity | 0.0 | 2.3 | 19.1 | 16.5 | 43.0 | 19.1 | 0.0 | 15.3% | 16.6% | 4.3% | 24.5% | 10% |
| ITI Pharma and Healthcare | 0.0 | 0.0 | 0.0 | 0.0 | 14.0 | 79.8 | 6.2 | 21.7% | 21.4% | 17.3% | 26.9% | 49% |
| Nifty Healthcare Index TRI | 0.0 | 0.0 | 0.0 | 0.0 | 24.9 | 67.7 | 7.4 | 21.8% | 22.2% | 15.6% | 27.3% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is Nifty Healthcare Index TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 11-11-2021. Past returns do not promise future returns.
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 01-11-2021 to 29-10-2026: 60 instalments, ₹6,00,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Aditya Birla Sun Life International EquityAditya Birla Sun Life International Equity Fund (Direct) | ₹6,00,000 | ₹9,22,858 | ₹3,22,858 | 17.3% |
| ITI Pharma and HealthcareITI Pharma and Healthcare Fund (Direct) | ₹6,00,000 | ₹9,07,480 | ₹3,07,480 | 16.6% |
Aditya Birla Sun Life International EquityAditya Birla Sun Life International Equity Fund (Direct)
ITI Pharma and HealthcareITI Pharma and Healthcare Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Aditya Birla Sun Life International Equity Fund (Direct) | ITI Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +13.97% | +9.43% |
| Standard deviation | 13.70% | 13.63% |
| Sharpe ratio | 0.64 | 0.31 |
| Sortino ratio | 0.89 | 0.44 |
| Maximum drawdown | −8.3% (30-03-2026) | −11.7% (29-01-2026) |
| Beta | -- | 0.91 |
| Alpha | -- | −1.48% |
From daily NAVs, 29-10-2025 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Aditya Birla Sun Life International Equity Fund (Direct) | ITI Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +24.46% | +20.30% |
| Standard deviation | 12.33% | 14.17% |
| Sharpe ratio | 1.49 | 1.01 |
| Sortino ratio | 2.16 | 1.41 |
| Maximum drawdown | −13.9% (07-04-2025) | −17.1% (03-03-2025) |
| Beta | -- | 0.90 |
| Alpha | -- | +0.31% |
From daily NAVs, 27-10-2023 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Aditya Birla Sun Life International Equity Fund (Direct) | ITI Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +11.96% | +14.34% |
| Standard deviation | 14.26% | 13.44% |
| Sharpe ratio | 0.41 | 0.63 |
| Sortino ratio | 0.58 | 0.89 |
| Maximum drawdown | −27.5% (24-03-2020) | −17.7% (17-06-2022) |
| Beta | -- | 0.84 |
| Alpha | -- | +1.08% |
From daily NAVs, 02-01-2013 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Aditya Birla Sun Life International Equity Fund (Direct)
ITI Pharma and Healthcare Fund (Direct)
Nifty Healthcare Index TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund (Direct) | −16.6% | 15-11-2021 | 03-10-2022 | 27-01-2023 | 4 months | −3.4% |
| ITI Pharma and Healthcare Fund (Direct) | −17.7% | 13-01-2022 | 17-06-2022 | 16-06-2023 | 12 months | −4.2% |
| Nifty Healthcare Index TRI | −18.3% | 31-12-2021 | 17-06-2022 | 30-06-2023 | 12 months | −2.9% |
From daily values since 11-11-2021, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Aditya Birla Sun Life International Equity Fund (Direct)
ITI Pharma and Healthcare Fund (Direct)
Nifty Healthcare Index TRI
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 3-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Aditya Birla Sun Life International Equity Fund (Direct)
ITI Pharma and Healthcare Fund (Direct)
Nifty Healthcare Index TRI
Against Nifty Healthcare Index TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund (Direct) | 34% | -13% | 19.14% |
| ITI Pharma and Healthcare Fund (Direct) | 94% | 87% | 5.10% |
From month-end values since 11-11-2021. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: Portfolio Overlap
From each fund's latest monthly portfolio: Aditya Birla Sun Life International Equity Fund, September 2026; ITI Pharma and Healthcare Fund, September 2026
Holdings in common
- Overlap
- 0.0%
- Held by both
- 0
- Only in Aditya Birla Sun Life International Equity
- 0
- Only in ITI Pharma and Healthcare
- 37
Overlap: for each holding both funds own, the smaller of its two weights, added up. 0.0% means 0.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Aditya Birla Sun Life International Equity Fund
Every holding of this fund is also held by the other.
Largest holdings only in ITI Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Sun Pharmaceutical Industries Limited | 11.96% |
| Divi's Laboratories Limited | 9.51% |
| Apollo Hospitals Enterprise Limited | 5.45% |
| Torrent Pharmaceuticals Limited | 4.78% |
| Dr. Reddy's Laboratories Limited | 4.78% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Aditya Birla Sun Life International Equity | ITI Pharma and Healthcare |
|---|---|---|
| Equity | 93.5% | 99.3% |
| Debt | 0.0% | 0.0% |
| Cash and others | 6.5% | 0.7% |
Market cap of stocks
| Market cap | Aditya Birla Sun Life International Equity | ITI Pharma and Healthcare |
|---|---|---|
| Large Cap | 0.0% | 35.9% |
| Mid Cap | 0.0% | 40.5% |
| Small Cap | 0.0% | 23.0% |
| Foreign stocks | 93.5% | 0.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Aditya Birla Sun Life International Equity | ITI Pharma and Healthcare |
|---|---|---|
| Pharmaceuticals & Biotechnology | 8.3% | 74.8% |
| Healthcare Services | 0.0% | 20.9% |
| IT - Software | 15.0% | 0.0% |
| IT - Hardware | 7.7% | 0.0% |
| Retailing | 6.6% | 0.0% |
| Banks | 5.5% | 0.0% |
| Industrial Manufacturing | 5.2% | 0.0% |
| Chemicals & Petrochemicals | 1.6% | 0.9% |
| Healthcare Equipment & Supplies | 0.0% | 1.5% |
| Consumer Durables | 1.1% | 1.2% |
The six largest sectors of each fund's stocks, % of the fund.
Aditya Birla Sun Life International Equity vs ITI Pharma and Healthcare: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Aditya Birla Sun Life International Equity Fund | ITI Pharma and Healthcare Fund |
|---|---|---|
| Total expense ratio (Direct) | 2.00% | 0.89% |
| Base expense ratio (Direct) | 1.60% | 0.58% |
| Total expense ratio (Regular) | 2.55% | 2.59% |
| Base expense ratio (Regular) | 2.08% | 2.10% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Aditya Birla Sun Life International Equity with
Aditya Birla Sun Life International Equity Fund vs ITI Pharma and Healthcare Fund: Frequently Asked Questions
What is the difference between Aditya Birla Sun Life International Equity Fund and ITI Pharma and Healthcare Fund?
Aditya Birla Sun Life International Equity Fund is a Thematic fund, ITI Pharma and Healthcare Fund is a Thematic fund, run by Aditya Birla Sun Life Mutual Fund and ITI Mutual Fund. Their portfolios overlap 0.0%. Aditya Birla Sun Life International Equity Fund charges 2.00% a year and ITI Pharma and Healthcare Fund 0.89%.
Which has given higher returns, Aditya Birla Sun Life International Equity Fund or ITI Pharma and Healthcare Fund?
Over 1 year: Aditya Birla Sun Life International Equity Fund +13.97%, ITI Pharma and Healthcare Fund +9.43%. Over 3 years: Aditya Birla Sun Life International Equity Fund +24.46% a year, ITI Pharma and Healthcare Fund +20.30% a year. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Aditya Birla Sun Life International Equity Fund or ITI Pharma and Healthcare Fund?
ITI Pharma and Healthcare Fund charges less: 0.89% a year against 2.00%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Aditya Birla Sun Life International Equity Fund and ITI Pharma and Healthcare Fund overlap?
0.0%. They hold 0 of the same securities. From each fund's latest monthly portfolio.
Which is riskier, Aditya Birla Sun Life International Equity Fund or ITI Pharma and Healthcare Fund?
On SEBI's riskometer, Aditya Birla Sun Life International Equity Fund is rated Very High and ITI Pharma and Healthcare Fund Very High. Over 3 years, the standard deviation of daily returns was 12.33% and 14.17% a year.
Which is better for SIP, Aditya Birla Sun Life International Equity Fund or ITI Pharma and Healthcare Fund?
Over the last 3 years, a monthly SIP of ₹10,000 from 03-10-2023 to 29-10-2026 grew to ₹5,05,796 in Aditya Birla Sun Life International Equity Fund (XIRR 20.9% a year) and ₹4,46,688 in ITI Pharma and Healthcare Fund (XIRR 12.3% a year). Both received 37 instalments. Past returns do not promise future returns.
Can I invest in both Aditya Birla Sun Life International Equity Fund and ITI Pharma and Healthcare Fund?
Yes. 0.0% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Who manages Aditya Birla Sun Life International Equity Fund and ITI Pharma and Healthcare Fund?
Aditya Birla Sun Life International Equity Fund: Dhaval Joshi. ITI Pharma and Healthcare Fund: Animesh Singh, Nilay Dalal.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.